e-learning
resources
Berlin 2008
Sunday, 05.10.2008
New insights into the pathogenesis of idiopathic pulmonary fibrosis and sarcoidosis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Chemokine mRNA expression profiling in pulmonary sarcoidosis
E. Kriegova, R. Fillerova, A. Arakelyan, F. Mrazek, B. Hutyrova, V. Kolek, R. du Bois, M. Petrek (Olomouc, Czech Republic; Denver, CO, United States Of America)
Source:
Annual Congress 2008 - New insights into the pathogenesis of idiopathic pulmonary fibrosis and sarcoidosis
Session:
New insights into the pathogenesis of idiopathic pulmonary fibrosis and sarcoidosis
Session type:
Oral Presentation
Number:
200
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Kriegova, R. Fillerova, A. Arakelyan, F. Mrazek, B. Hutyrova, V. Kolek, R. du Bois, M. Petrek (Olomouc, Czech Republic; Denver, CO, United States Of America). Chemokine mRNA expression profiling in pulmonary sarcoidosis. Eur Respir J 2008; 32: Suppl. 52, 200
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Pulmonary sarcoidosis
Definition and history of sarcoidosis
ERS clinical practice guidelines on treatment of sarcoidosis
Related content which might interest you:
Expression profiling in sarcoidosis, EAA and IPF
Source: Annual Congress 2010 - Different patterns of interstitial lung disease
Year: 2010
Cell-specific expression of peroxiredoxins in human lung and pulmonary sarcoidosis
Source: Eur Respir J 2001; 18: Suppl. 33, 76s
Year: 2001
Chemokines and chemokine receptors mRNA expression in whole blood of COPD patients
Source: Annual Congress 2010 - Cell biology and immunology of lung disease
Year: 2010
Chemokines and chemokine receptors mRNA expression in lavage of COPD patients
Source: Annual Congress 2009 - COPD: basic science and clinical studies
Year: 2009
MiRNA expression profile is altered upon cystic fibrosis pulmonary exacerbation
Source: International Congress 2019 – Infection and inflammation in cystic fibrosis
Year: 2019
Chemokine and their receptors mRNA expression in brush-biopsies of nasopharynx in bronchial asthma patients
Source: Annual Congress 2011 - Asthma mechanisms
Year: 2011
Functional expression of TLR9 on BAL clls from sarcoidosis patients
Source: Annual Congress 2008 - Airway cell biology and immunology
Year: 2008
Differential expression of IL-33 and HMGB1 in the lungs of stable cystic fibrosis patients
Source: Eur Respir J 2014; 44: 802-805
Year: 2014
High ICAM-1 gene expression in pulmonary fibroblasts of COPD patients
Source: Eur Respir J 2004; 24: Suppl. 48, 454s
Year: 2004
ETS-1 mRNA and its association with T-BET and Th1 cytokine expression in active pulmonary sarcoidosis.
Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes
Year: 2018
NHLRC2 mRNA and protein expression in idiopathic pulmonary fibrosis
Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia
Year: 2021
High mRNA expressions of KLF2 improve post operative prognosis of pulmonary adenocarcinoma correlation with chemokine receptor CCR7 and genetical mutations of p53
Source: Annual Congress 2012 - Prognosis of lung cancer
Year: 2012
Evaluation of mRNA expression profiling of NF-?B mediated signaling in COPD patients.
Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies
Year: 2020
Decreased TLR2 gene expression in alveolar macrophages from sarcoidosis patients with Löfgren‘s syndrome
Source: Annual Congress 2007 - COPD, sarcoidosis, idiopathic pulmonary fibrosis, cystic fibrosis, gastro-oesophageal reflux and cough variant asthma - pathogenesis and differential diagnosis
Year: 2007
Decreased expression of VEGFR-2 mRNA in pulmonary vessels of COPD patients
Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of COPD
Year: 2009
Expression of mRNA encoding IL-8 and CXCR‘s in blood and lavage of COPD patients
Source: Eur Respir J 2007; 30: Suppl. 51, 584s
Year: 2007
Expression of mRNA of selected inflammatory markers in BALf cells from patients with sarcoidosis and idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2017 – IPF: from the bench to the bedside
Year: 2017
microRNA profiling in pulmonary fibroblasts in COPD
Source: Annual Congress 2011 - Molecular: pathology of infectious and inflammatory lung disease
Year: 2011
Pleural and systemic cytokine expression profiles in patients with lung cancer
Source: International Congress 2018 – Lung cancer: modern therapies and beyond
Year: 2018
Correlation of eotaxin-3 gene expression and other IL-13-induced genes in patients with asthma
Source: Virtual Congress 2021 – New insight into the immunology of allergies, asthma and COPD: from mouse to man
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept